MediciNova, Inc.

MediciNova, Inc.verified

MNOV

Price:

$1.98

Market Cap:

$97.11M

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of ...[Read more]

Industry

Biotechnology

IPO Date

2006-12-08

Stock Exchange

NASDAQ

Ticker

MNOV

The Current Ratio as of October 2024 (TTM) for MediciNova, Inc. (MNOV) is 18.24

According to MediciNova, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.24. This represents a change of 1.59% compared to the average of 17.96 of the last 4 quarters.

MediciNova, Inc. (MNOV) Historical Current Ratio (quarterly & annually)

How has MNOV Current Ratio performed in the past?

The mean historical Current Ratio of MediciNova, Inc. over the last ten years is 19.25. The current 18.24 Current Ratio has changed 9.37% with respect to the historical average. Over the past ten years (40 quarters), MNOV's Current Ratio was at its highest in in the March 2018 quarter at 53.02. The Current Ratio was at its lowest in in the December 2014 quarter at 7.61.

Quarterly (TTM)
Annual

Average

19.25

Median

17.06

Minimum

7.61

Maximum

28.86

MediciNova, Inc. (MNOV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of MediciNova, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 191.18%

Maximum Annual Current Ratio = 28.86

Minimum Annual Increase = -75.63%

Minimum Annual Current Ratio = 7.61

Quarterly (TTM)
Annual
YearCurrent RatioChange
202315.61-15.67%
202218.51-27.20%
202125.42-8.15%
202027.67-4.10%
201928.860.79%
201828.63191.18%
20179.83-35.12%
201615.16-0.61%
201515.25100.32%
20147.61-75.63%

MediciNova, Inc. (MNOV) Average Current Ratio

How has MNOV Current Ratio performed in the past?

The current Current Ratio of MediciNova, Inc. (MNOV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

19.84

5-year avg

23.21

10-year avg

19.25

MediciNova, Inc. (MNOV) Current Ratio vs. Peers

How is MNOV’s Current Ratio compared to its peers?

MediciNova, Inc.’s Current Ratio is greater than Aerovate Therapeutics, Inc. (6.51), greater than Adagene Inc. (2.50), greater than Acrivon Therapeutics, Inc. Common Stock (16.16), greater than Rezolute, Inc. (13.39), greater than AN2 Therapeutics, Inc. (10.61), less than Eliem Therapeutics, Inc. (0), less than Molecular Partners AG (60.41), greater than Champions Oncology, Inc. (14.58), greater than Cyteir Therapeutics, Inc. (0.69), less than Anebulo Pharmaceuticals, Inc. (21.89), greater than PMV Pharmaceuticals, Inc. (13.46), less than Pharvaris N.V. (19.22), less than PepGen Inc. (18.45), greater than null (7.45),

Build a custom stock screener for MediciNova, Inc. (MNOV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediciNova, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MediciNova, Inc. (MNOV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MediciNova, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is MediciNova, Inc.'s Current Ratio?

How is the Current Ratio calculated for MediciNova, Inc. (MNOV)?

What is the highest Current Ratio for MediciNova, Inc. (MNOV)?

What is the 3-year average Current Ratio for MediciNova, Inc. (MNOV)?

What is the 5-year average Current Ratio for MediciNova, Inc. (MNOV)?

How does the current Current Ratio for MediciNova, Inc. (MNOV) compare to its historical average?